2025-10-28 23:00:16
Latest Post
Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director
Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores
Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore
Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore
Tata Capital Ltd posts consolidated PAT of Rs. 1097.32 crores in Q2FY26
Stock Report
Novartis India Ltd posts PAT of Rs. 24.22 crores in Q2FY26
Posted On : 2025-10-28 18:03:18( TIMEZONE : IST )
Novartis India Limited has reported Standalone financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 99.73 crores during the period ended September 30, 2025 as compared to Rs. 98.16 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 24.22 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 27.62 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 9.81 for the period ended September 30, 2025 as compared to Rs. 11.19 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹ 99.73 crs | ₹98.16 crs |  1.60% |
| Net Profit | ₹24.22 crs | ₹27.62 crs |  -12.31% |
| EPS | ₹9.81 | ₹11.19 | -12.33% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs. 99.73 crores during the period ended September 30, 2025 as compared to Rs.97.42 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.24.22 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.20.41 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.9.81 for the period ended September 30, 2025 as compared to Rs.8.27 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹ 99.73 crs | ₹97.42 crs | 2.37% |
| Net Profit | ₹24.22 crs | ₹20.41 crs | 18.67% |
| EPS | ₹9.81 | ₹8.27 | 18.62% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.197.89 crores during the 6 Months period ended September 30, 2025 as compared to Rs.200.12 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.51.84 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.46.15 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.21 for the 6 Months period ended September 30, 2025 as compared to Rs.18.69 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹197.89 crs | ₹200.12 crs | -1.11% |
| Net Profit | ₹51.84 crs | ₹46.15 crs | 12.33% |
| EPS | ₹21 | ₹18.69 | 12.36% |
Shares of Novartis India Limited was last trading in BSE at Rs. 858.35 as compared to the previous close of Rs. 863.40. The total number of shares traded during the day was 4017 in over 277 trades.
The stock hit an intraday high of Rs. 877.70 and intraday low of 855.00. The net turnover during the day was Rs. 3469312.00.
